🧪 Beta — BiohacksAI is under active development. Data and features may change.
B
BiohacksAI
Evidence-Based Biohacking
BetaPatent Pending

Bay 293

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Bay 293, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

olanzapine
19 shared targets
clozapine
22 shared targets
brexpiprazole
20 shared targets
nantenine
17 shared targets
risperidone
19 shared targets
clemastine
17 shared targets
spiroxatrine
14 shared targets
Loxapine
21 shared targets · score 50.9
niguldipine
18 shared targets
ritanserin
17 shared targets
Loading evidence profile...

This evidence profile for Bay 293 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.